These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 26889655

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. 2-Methoxyestradiol mediates the protective effects of estradiol in monocrotaline-induced pulmonary hypertension.
    Tofovic SP, Zhang X, Jackson EK, Dacic S, Petrusevska G.
    Vascul Pharmacol; 2006 Dec; 45(6):358-67. PubMed ID: 16872912
    [Abstract] [Full Text] [Related]

  • 3. The HMG-CoA reductase inhibitor, pravastatin, prevents the development of monocrotaline-induced pulmonary hypertension in the rat through reduction of endothelial cell apoptosis and overexpression of eNOS.
    Guerard P, Rakotoniaina Z, Goirand F, Rochette L, Dumas M, Lirussi F, Bardou M.
    Naunyn Schmiedebergs Arch Pharmacol; 2006 Sep; 373(6):401-14. PubMed ID: 16896805
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Celecoxib but not the combination of celecoxib+atorvastatin prevents the development of monocrotaline-induced pulmonary hypertension in the rat.
    Rakotoniaina Z, Guerard P, Lirussi F, Rochette L, Dumas M, Goirand F, Bardou M.
    Naunyn Schmiedebergs Arch Pharmacol; 2008 Sep; 378(3):241-51. PubMed ID: 18542928
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effect of limonene and sobrerol on monocrotaline-induced lung alterations and pulmonary hypertension.
    Touvay C, Vilain B, Carré C, Mencia-Huerta JM, Braquet P.
    Int Arch Allergy Immunol; 1995 Sep; 107(1-3):272-4. PubMed ID: 7542078
    [Abstract] [Full Text] [Related]

  • 17. Gene transfer of hepatocyte growth factor with prostacyclin synthase in severe pulmonary hypertension of rats.
    Ono M, Sawa Y, Fukushima N, Suhara H, Nakamura T, Yokoyama C, Tanabe T, Matsuda H.
    Eur J Cardiothorac Surg; 2004 Dec; 26(6):1092-7. PubMed ID: 15541968
    [Abstract] [Full Text] [Related]

  • 18. Protection by oestradiol against the development of cardiovascular changes associated with monocrotaline pulmonary hypertension in rats.
    Farhat MY, Chen MF, Bhatti T, Iqbal A, Cathapermal S, Ramwell PW.
    Br J Pharmacol; 1993 Oct; 110(2):719-23. PubMed ID: 8242243
    [Abstract] [Full Text] [Related]

  • 19. A novel hydrodynamic approach of drag-reducing polymers to improve left ventricular hypertrophy and aortic remodeling in spontaneously hypertensive rats.
    Zhang X, Wang X, Hu F, Zhou B, Chen HB, Zha D, Liu Y, Guo Y, Zheng L, Xiu J.
    Int J Nanomedicine; 2016 Oct; 11():6743-6751. PubMed ID: 28008249
    [Abstract] [Full Text] [Related]

  • 20. Thymosin Beta 4 protects mice from monocrotaline-induced pulmonary hypertension and right ventricular hypertrophy.
    Wei C, Kim IK, Li L, Wu L, Gupta S.
    PLoS One; 2014 Oct; 9(11):e110598. PubMed ID: 25412097
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.